Instituto de Química Médica (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.
Molecules. 2021 Jan 16;26(2):445. doi: 10.3390/molecules26020445.
Cyclic and macrocyclic peptides constitute advanced molecules for modulating protein-protein interactions (PPIs). Although still peptide derivatives, they are metabolically more stable than linear counterparts, and should have a lower degree of flexibility, with more defined secondary structure conformations that can be adapted to imitate protein interfaces. In this review, we analyze recent progress on the main methods to access cyclic/macrocyclic peptide derivatives, with emphasis in a few selected examples designed to interfere within PPIs. These types of peptides can be from natural origin, or prepared by biochemical or synthetic methodologies, and their design could be aided by computational approaches. Some advances to facilitate the permeability of these quite big molecules by conjugation with cell penetrating peptides, and the incorporation of β-amino acid and peptoid structures to improve metabolic stability, are also commented. It is predicted that this field of research could have an important future mission, running in parallel to the discovery of new, relevant PPIs involved in pathological processes.
环状和大环肽是调节蛋白质-蛋白质相互作用(PPIs)的先进分子。虽然它们仍然是肽衍生物,但与线性对应物相比,它们在代谢上更加稳定,并且应该具有较低的柔韧性,具有更确定的二级结构构象,可以适应模拟蛋白质界面。在这篇综述中,我们分析了获得环状/大环肽衍生物的主要方法的最新进展,重点介绍了几个旨在干扰 PPIs 的选定示例。这些类型的肽可以来自天然来源,也可以通过生化或合成方法制备,并且可以通过计算方法辅助其设计。还评论了通过与细胞穿透肽缀合来促进这些相当大的分子的通透性的一些进展,以及通过引入β-氨基酸和肽类似物结构来提高代谢稳定性的进展。可以预测,这个研究领域可能具有重要的未来任务,与发现涉及病理过程的新的、相关的 PPI 平行进行。